BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aladrén BS, González-Lama Y, García-Alvarado M, Sierra M, Barrio JA, Vicente VP, Hernández L, Velayos B, Garcia LA, Relea L, Suarez P, Atienza R, Vásquez M, Fernández-Salazar L, Muñoz F; GEICYL (group of inflammatory bowel disease of Castilla y León). Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life. Endosc Int Open 2019;7:E743-50. [PMID: 31157291 DOI: 10.1055/a-0839-4514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bak MTJ, Albéniz E, East JE, Coelho-Prabhu N, Suzuki N, Saito Y, Matsumoto T, Banerjee R, Kaminski MF, Kiesslich R, Coron E, de Vries AC, van der Woude CJ, Bisschops R, Hart AL, Itzkowitz SH, Pioche M, Moons LMG, Oldenburg B. Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study. Gastrointest Endosc 2023;97:767-779.e6. [PMID: 36509111 DOI: 10.1016/j.gie.2022.12.005] [Reference Citation Analysis]
2 Akiyama S, Sakamoto T, Steinberg JM, Saito Y, Tsuchiya K. Evolving roles of magnifying endoscopy and endoscopic resection for neoplasia in inflammatory bowel diseases. World J Gastrointest Oncol 2022; 14(3): 646-653 [DOI: 10.4251/wjgo.v14.i3.646] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rubín de Célix C, Chaparro M, Moreno JA, Santander C, Gisbert JP. Colorectal cancer surveillance with chromoendoscopy in inflammatory bowel disease: results from a real-life experience. Scand J Gastroenterol 2021;56:806-11. [PMID: 33905275 DOI: 10.1080/00365521.2021.1918758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sicilia B, Vicente R, Arias L, Echarri A, Zabana Y, Mañosa M, Beltrán B, Barreiro-de Acosta M. Recommendations of the Spanish Working Group on Crohn’s disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa — GETECCU) on dysplasia screening in inflammatory bowel disease patients. Gastroenterología y Hepatología (English Edition) 2021;44:435-447. [DOI: 10.1016/j.gastre.2020.12.002] [Reference Citation Analysis]
5 Sicilia B, Vicente R, Arias L, Echarri A, Zabana Y, Mañosa M, Beltrán B, Barreiro-de Acosta M; en nombre de GETECCU. Recommendations of the Spanish Working Group on Crohn's disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU) on dysplasia screening in inflammatory bowel disease patients. Gastroenterol Hepatol 2021;44:435-47. [PMID: 33592179 DOI: 10.1016/j.gastrohep.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]